Carl LeBel
2019
In 2019, Carl LeBel earned a total compensation of $2.2M as Chief Development Officer at Korro Bio, a 364% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,000 |
|---|---|
| Option Awards | $1,605,602 |
| Salary | $370,417 |
| Other | $11,200 |
| Total | $2,217,219 |
LeBel received $1.6M in option awards, accounting for 72% of the total pay in 2019.
LeBel also received $230K in non-equity incentive plan, $370.4K in salary and $11.2K in other compensation.
Rankings
In 2019, Carl LeBel's compensation ranked 5,397th out of 13,971 executives tracked by ExecPay. In other words, LeBel earned more than 61.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,397 out of 13,971 | 61st |
Division Manufacturing | 2,017 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 715 out of 2,200 | 68th |
Industry group Drugs | 599 out of 1,886 | 68th |
Industry Pharmaceutical Preparations | 445 out of 1,398 | 68th |
Source: SEC filing on April 29, 2020.
LeBel's colleagues
We found two more compensation records of executives who worked with Carl LeBel at Korro Bio in 2019.